Fund Holdings — BAKER BROS. ADVISORS LP

Total Portfolio Value:
$9.65B
Total Bought:
$1.02B
Total Sold:
$48.05M
Net Transaction:
+$973.79M
Notable People:
Scott Lawrence Lessing, Baker Bros. Advisors (Gp), Llc
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
BeOne Medicines AGADR(ONC)10,568,89710,568,8970$1.51B$2.37B24.59%+$864.96M
Incyte Corporation(INCY)30,738,52430,739,020+496$1.86B$2.03B21.06%+$168.48M
ACADIA Pharmaceuticals Inc.42,877,91642,877,9160$696.77M$659.46M6.83%-$37.30M
Summit Therapeutics Inc.(SMMT)23,222,22224,424,865+1,202,643$181.13M$534.90M5.54%+$353.77M
Madrigal Pharmaceuticals, Inc.(MDGL)1,974,5901,974,5900$553.20M$419.05M4.34%-$134.15M
Revolution Medicines, Inc.(RVMD)7,569,0907,569,0900$293.76M$343.26M3.56%+$49.50M
Rhythm Pharmaceuticals, Inc.(RYTM)6,398,3656,398,366+1$262.72M$335.21M3.47%+$72.49M
Insmed Incorporated(INSM)3,576,0384,415,918+839,880$239.59M$322.36M3.34%+$82.77M
Kymera Therapeutics, Inc.(KYMR)5,995,9285,995,929+1$178.98M$283.79M2.94%+$104.81M
Bicycle Therapeutics plcADS9,399,9609,399,9600$190.26M$212.72M2.20%+$22.47M
Edgewise Therapeutics, Inc.(EWTX)5,840,0595,840,0590$105.18M$155.87M1.62%+$50.69M
Replimune Group, Inc.(REPL)10,045,33611,045,336+1,000,000$90.41M$121.06M1.25%+$30.65M
Alkermes plcSHS(ALKS)4,181,7514,181,7510$100.78M$117.05M1.21%+$16.27M
Denali Therapeutics Inc.(DNLI)3,731,6953,731,6950$86.65M$108.70M1.13%+$22.05M
Insmed IncorporatedNOTE 0 75 6 1 2028(INSM)000$90.41M$98.33M1.02%+$7.91M
Ultragenyx Pharmaceutical Inc.(RARE)1,466,5471,576,114+109,567$60.28M$87.55M0.91%+$27.28M
Nurix Therapeutics, Inc.(NRIX)3,882,1253,882,1250$81.02M$87.23M0.90%+$6.21M
Entrada Therapeutics, Inc.(TRDA)4,865,8194,865,8190$69.34M$77.76M0.81%+$8.42M
Immatics N.V.SHS(IMTX)6,443,3986,443,3980$74.87M$73.52M0.76%-$1.35M
AbCellera Biologics Inc.(ABCL)27,525,64027,525,6400$81.48M$71.57M0.74%-$9.91M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)2,818,3232,818,3230$52.62M$70.43M0.73%+$17.81M
IGM Biosciences, Inc.4,090,3164,092,310+1,994$28.10M$67.69M0.70%+$39.59M
argenx SEADR(ARGX)111,904111,9040$48.12M$60.66M0.63%+$12.54M
Stoke Therapeutics, Inc.(STOK)4,368,4434,368,4430$59.02M$53.69M0.56%-$5.33M
Immunocore Holdings plcADS(IMCR)1,515,3181,515,3180$51.35M$47.17M0.49%-$4.18M
Kodiak Sciences Inc.(KOD)17,310,49017,310,4900$40.68M$45.18M0.47%+$4.50M
Sera Prognostics, Inc.CL A(SERA)5,434,3995,434,3990$32.17M$42.39M0.44%+$10.22M
CRISPR Therapeutics AGNAMEN AKT(CRSP)100,000843,075+743,075$5.40M$39.61M0.41%+$34.21M
Xenon Pharmaceuticals Inc.(XENE)993,679993,6790$38.74M$39.12M0.41%+$377.6K
Immunovant, Inc.(IMVT)464,7181,225,410+760,692$12.27M$34.94M0.36%+$22.67M
Cerus Corporation(CERS)19,477,33919,477,3390$34.28M$33.89M0.35%-$389.5K
IDEAYA Biosciences, Inc.(IDYA)1,062,1231,062,1230$37.29M$33.65M0.35%-$3.64M
Roivant Sciences Ltd.SHS(ROIV)2,798,7162,798,7160$29.58M$32.30M0.33%+$2.71M
Akero Therapeutics, Inc.1,097,0821,097,0820$25.74M$31.48M0.33%+$5.74M
Krystal Biotech, Inc.(KRYS)169,934169,9340$31.21M$30.93M0.32%-$273.6K
Celcuity Inc.(CELC)1,874,9781,874,9780$30.71M$27.96M0.29%-$2.76M
Monte Rosa Therapeutics, Inc.(GLUE)4,916,0954,916,0950$18.39M$26.06M0.27%+$7.67M
Dyne Therapeutics, Inc.(DYN)672,096672,0960$23.72M$24.14M0.25%+$423.4K
Biomea Fusion, Inc.(BMEA)2,108,9492,108,9490$9.49M$21.30M0.22%+$11.81M
Bicara Therapeutics Inc.0833,333+833,333$0$21.22M0.22%+$21.22M
Prelude Therapeutics Incorporated(PRLD)10,123,82410,123,8240$38.57M$20.96M0.22%-$17.62M
Centessa Pharmaceuticals plcADS549,2121,227,178+677,966$4.96M$19.62M0.20%+$14.66M
Neurogene Inc.(NGNE)456,015456,0150$16.59M$19.13M0.20%+$2.54M
Praxis Precision Medicines, Inc.(PRAX)131,533323,105+191,572$5.44M$18.59M0.19%+$13.15M
Alumis Inc.1,562,5001,562,5000$20.78M$16.69M0.17%-$4.09M
Merus N.V.300,000300,0000$17.75M$14.99M0.16%-$2.76M
TScan Therapeutics, Inc.(TCRX)2,784,7922,784,7920$16.29M$13.87M0.14%-$2.42M
Neumora Therapeutics, Inc.(NMRA)1,034,6001,034,6000$10.17M$13.67M0.14%+$3.50M
Xencor, Inc.(XNCR)545,431670,431+125,000$10.33M$13.48M0.14%+$3.16M
2seventy bio, Inc.2,497,5262,497,5260$9.62M$11.79M0.12%+$2.17M
Fate Therapeutics, Inc.(FATE)2,997,7722,997,7720$9.83M$10.49M0.11%+$659.5K
Arvinas, Inc.(ARVN)0405,576+405,576$0$9.99M0.10%+$9.99M
Sana Biotechnology, Inc.(SANA)2,380,9492,380,9490$13.00M$9.90M0.10%-$3.10M
Design Therapeutics, Inc.(DSGN)1,695,2941,743,725+48,431$5.68M$9.38M0.10%+$3.70M
Ionis Pharmaceuticals, Inc.(IONS)0223,470+223,470$0$8.95M0.09%+$8.95M
Ceryvyn Therapeutics LimitedADS(CKDXF)2,173,6222,173,6220$4.20M$8.85M0.09%+$4.65M
Celldex Therapeutics, Inc.(CLDX)247,644247,6440$9.17M$8.42M0.09%-$747.9K
Relay Therapeutics, Inc.(RLAY)1,160,1171,160,1170$7.56M$8.21M0.09%+$649.7K
Verve Therapeutics, Inc.1,691,5301,691,5300$8.25M$8.19M0.08%-$67.7K
Taysha Gene Therapies, Inc.(TSHA)4,004,7564,004,7560$8.97M$8.05M0.08%-$921.1K
Mirum Pharmaceuticals, Inc.(MIRM)190,476190,4760$6.51M$7.43M0.08%+$916.2K
Contineum Therapeutics, Inc.CL A(CTNM)312,500312,5000$5.50M$5.98M0.06%+$478.1K
Tango Therapeutics, Inc.(TNGX)750,000750,0000$6.43M$5.78M0.06%-$660.0K
Skye Bioscience, Inc.(SKYE)500,0001,434,634+934,634$4.00M$5.61M0.06%+$1.60M
Vaxcyte, Inc.(PCVX)48,88548,8850$3.69M$5.59M0.06%+$1.89M
Crinetics Pharmaceuticals, Inc.103,927103,9270$4.65M$5.31M0.06%+$655.8K
DBV Technologies S.A.ADR7,307,1317,307,1310$5.85M$5.11M0.05%-$738.0K
KALA BIO, Inc.(KALA)891,335891,3350$6.32M$5.08M0.05%-$1.24M
Generation Bio Co.1,206,9571,944,945+737,988$3.40M$4.80M0.05%+$1.40M
Alector, Inc.927,264927,2640$4.21M$4.32M0.04%+$111.3K
Prime Medicine, Inc.(PRME)1,028,4661,028,4660$5.29M$3.98M0.04%-$1.31M
Sagimet Biosciences Inc.COM SER A(SGMT)1,381,8981,381,8980$4.73M$3.83M0.04%-$898.2K
Structure Therapeutics Inc.ADS085,500+85,500$0$3.75M0.04%+$3.75M
Arcturus Therapeutics Holdings Inc.(ARCT)151,329151,3290$3.68M$3.51M0.04%-$172.5K
HOOKIPA Pharma Inc.8,128,151812,814-7,315,337$4.81M$3.50M0.04%-$1.32M
Cypherpunk Technologies Inc.(CYPH)1,172,1751,172,1750$2.30M$3.01M0.03%+$715.0K
Enliven Therapeutics, Inc.114,833114,8330$2.68M$2.93M0.03%+$249.2K
Compass Therapeutics, Inc.(CMPX)1,557,6301,557,6300$1.56M$2.87M0.03%+$1.31M
Wave Life Sciences, Inc.SHS(WVE)0344,063+344,063$0$2.82M0.03%+$2.82M
Mersana Therapeutics, Inc.1,086,1151,086,1150$2.18M$2.05M0.02%-$130.3K
NewAmsterdam Pharma Company N.V.
ORDINARY SHARES
96,82796,711-116$1.86M$1.61M0.02%-$254.6K
Century Therapeutics, Inc.(IPSC)797,460797,4600$2.03M$1.36M0.01%-$669.9K
vTv Therapeutics Inc.CL A(VTVT)97,31497,3140$1.72M$1.32M0.01%-$398.5K
Aerovate Therapeutics, Inc.628,939628,9390$1.04M$1.31M0.01%+$270.4K
Pfizer Inc.(PFE)35,00035,0000$979.3K$1.01M0.01%+$33.6K
Protara Therapeutics, Inc.(TARA)536,832536,8320$1.12M$982.4K0.01%-$134.2K
Aligos Therapeutics, Inc.(ALGS)083,055+83,055$0$719.3K0.01%+$719.3K
BioCryst Pharmaceuticals, Inc.(BCRX)75,77875,7780$468.3K$575.9K0.01%+$107.6K
PMV Pharmaceuticals, Inc.(PMVP)322,024322,0240$521.7K$479.8K0.00%-$41.9K
Foghorn Therapeutics Inc.(FHTX)45,02745,0270$258.9K$419.2K0.00%+$160.3K
Acrivon Therapeutics, Inc.52,88552,8850$306.7K$370.2K0.00%+$63.5K
Tyra Biosciences, Inc.(TYRA)10,60710,6070$169.6K$249.4K0.00%+$79.8K
Surrozen, Inc.W EXP 8 11 2026(SRZN)833,333833,3330$13.8K$8.6K0.00%-$5.3K
Achilles Therapeutics plcADS1,108,7670-1,108,767$903.6K$0—-$903.6K
Adaptimmune Therapeutics plcADR(ADAPY)2,343,6950-2,343,695$2.28M$0—-$2.28M
Aligos Therapeutics, Inc.2,076,4000-2,076,400$726.7K$0—-$726.7K
Athira Pharma, Inc.3,153,8070-3,153,807$8.36M$0—-$8.36M
Cerevel Therapeutics Holdings, Inc.683,5880-683,588$27.95M$0—-$27.95M
Sage Therapeutics, Inc.171,0260-171,026$1.86M$0—-$1.86M
Talis Biomedical Corporation508,3230-508,323$4.40M$0—-$4.40M
Page 1 of 2
BAKER BROS. ADVISORS LP — 13F Holdings — Q3 2024 | TickerTrail